Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Seminars in Cancer Biology|April 15, 2022
EGFR signaling pathway as therapeutic target in human cancersElena Levantini, Giorgia Maroni, Marzia Del Re, et al.Molecular Carcinogenesis|October 23, 2008
Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: implications for non-small cell lung cancer tumor colonizationYakov Peter, Alejandro Comellas, Elena Levantini, et al.Molecular Cancer|June 6, 2013
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survivalSerena Lucotti, Giuseppe Rainaldi, Monica Evangelista, et al.Biophysical Chemistry|July 20, 2019
Fluorescence imaging of biochemical relationship between ubiquitinated histone 2A and Polycomb complex protein BMI1Barbara Storti, Simone Civita, Paolo Faraci, et al.Oligonucleotides|January 19, 2011
The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cellsFrancesca Patella, Serena Lucotti, Milena Rizzo, et al.Journal of Cellular and Molecular Medicine|December 1, 2010
miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescenceMilena Rizzo, Laura Mariani, Letizia Pitto, et al.Magnetic Resonance in Medicine|August 12, 2006
Three-dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic miceShigeto Kubo, Elena Levantini, Susumu Kobayashi, et al.International Journal of Pharmaceutics|April 23, 2024
Pegylated-liposomes increase the efficacy of Idelalisib in lymphoma B-cellsGiorgia Maroni, Elena Tomassi, Donatella Valenti, et al.Current Genomics|February 3, 2011
The Fuzzy Logic of MicroRNA Regulation: A Key to Control Cell ComplexityAndrea Ripoli, Giuseppe Rainaldi, Milena Rizzo, et al.Nucleic Acid Therapeutics|July 27, 2012
The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulationMilena Rizzo, Laura Mariani, Sara Cavallini, et al.Pageof 10